Skip to main content
Adilia Hormigo, MD, Neurology, Bronx, NY

AdiliaHormigoMD

Neurology • Bronx, NY

Neurooncology

Leader of the Neuro-Oncology Program Montefiore Einstein Cancer Center

Join to view full profile

Dr. Hormigo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hormigo's full profile

Already have an account?

Summary

  • Adilia Hormigo, MD, PhD, is Leader, Neuro-Oncology Program, Co-Leader, Neuro-Oncology Multidisciplinary Disease Team at Montefiore Einstein Cancer Center and Professor, Hematology-Oncology, Neurosurgery, and Microbiology & Immunology at Albert Einstein College of Medicine. Dr. Hormigo’s translational research focuses on new strategies in cancer immunology, including personalized treatment for patients with malignant brain tumors, understanding and overcoming the tumor microenvironment resistance to treatment and defining biomarkers of treatment response. She has been a primary investigator of innovative clinical trials. Her work has been published in numerous peer-reviewed journals.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1999 - 2003
  • New York University
    New York UniversityPhD, 1995 - 1999
  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 1992 - 1995
  • University of Lisbon Faculty of Medicine
    University of Lisbon Faculty of MedicineClass of 1981

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2026
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CRI -V Foundation (CLIP) Investigator Cancer Research Institute, 2021
  • National Brain Tumor Society, Defeat Brain Tumor National Brain Tumor Society, 2020
  • The Memorial Sloan-Kettering Cancer Center Brain Tumor Center Memorial Sloan-Kettering Cancer Center, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma  
    Daniel Chiu1 , Jingjing Qi 2 , Tin Htwe Thin3 , Monica Garcia-Barros 3 , Brian Lee 2 , Mary Hahn1 , John Mandeli4 , Puneet Belani 5 , Kambiz Nael 6 , Omid Rashidipour ..., Cancer Resarch Communications, 1/25/2023

Lectures

  • Phase I study of PD-L1 inhibition with avelumab and laser interstitial thermal therapy in patients with recurrent glioblastoma. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Personalised Cancer Vaccines Are Finally Beating Hard to Treat Tumours
    Personalised Cancer Vaccines Are Finally Beating Hard to Treat TumoursJune 22nd, 2022
  • New Investigational Helmet Device Shrinks Glioblastoma
    New Investigational Helmet Device Shrinks GlioblastomaJuly 30th, 2021

Professional Memberships

  • American Academy of Neurology - AAN
    Member
  • American Neurological Association
    Fellow
  • Society for Neuro-Oncology
    Member
  • American Society for Clinical Oncology
    Member
  • American Association for Cancer Research
    Member
  • The Society for the Immunotherapy of Cancer
    Member

Other Languages

  • Portuguese, Spanish, French

External Links

Dr. Adilia Hormigo, Dr. Adilia Hormigo, MD, Dr. A Hormigo